1 Min Read
June 19 (Reuters) - Bayer AG : * Says Xofigo drug attested to have considerable benefit in treating certain
prostate cancer types by German reimbursement agency G-BA
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.